Circular RNA enrichment in platelets is a signature of transcriptome degradation

Blood

Volumn 127, Issue 9, 2016, Pages e1-e11

  Alhasan, Abd A ^a   Izuogu, Osagie G ^a   Al Balool, Haya H ^b   Steyn, Jannetta S ^a   Evans, Amanda ^c   Colzani, Maria ^c   Ghevaert, Cedric ^c   Mountford, Joanne C ^d,e   Marenah, Lamin ^e   Elliott, David J ^a   Santibanez Koref, Mauro ^a   Jackson, Michael S ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Kuwait Medical Genetics Centre   (Kuwait)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CIRCULAR RNA; RNA; TRANSCRIPTOME; UNCLASSIFIED DRUG; EXORIBONUCLEASE; RIBONUCLEASE R; RNA, CIRCULAR;

ARTICLE; CELL COUNT; COMPUTER MODEL; CONTROLLED STUDY; ERYTHROCYTE; EXON; HEK293 CELL LINE; HUMAN; HUMAN CELL; MEGAKARYOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA DEGRADATION; RNA SEQUENCE; SEQUENCE ANALYSIS; THROMBOCYTE; GENETICS; METABOLISM; REPRODUCIBILITY; RNA STABILITY;

BLOOD PLATELETS; EXONS; EXORIBONUCLEASES; HUMANS; MEGAKARYOCYTES; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RNA; RNA STABILITY; TRANSCRIPTOME;

EID: 84960421444     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-06-649434     Document Type: Article

References (62)

1. Deutsch VR, Tomer A. Megakaryocyte development and platelet production. Br J Haematol. 2006;134(5):453-466.
2. Garraud O, Cognasse F. Are Platelets Cells? And if Yes, are They Immune Cells? Front Immunol. 2015;6:70.
3. Migliaccio AR. Erythroblast enucleation. Haematologica. 2010;95(12):1985-1988.
4. Harker LA, Roskos LK, Marzec UM, et al. Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers. Blood. 2000;95(8):2514-2522.
5. Weyrich AS, Schwertz H, Kraiss LW, Zimmerman GA. Protein synthesis by platelets: historical and new perspectives. J Thromb Haemost. 2009;7(2):241-246.
6. Denis MM, Tolley ND, Bunting M, et al. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell. 2005;122(3):379-391.
7. Schwertz H, Tolley ND, Foulks JM, et al. Signaldependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med. 2006;203(11):2433-2440.
8. Freedman JE. A platelet transcriptome revolution. Blood. 2011;118(14):3760-3761.
9. Rowley JW, Oler AJ, Tolley ND, et al. Genomewide RNA-seq analysis of human and mouse platelet transcriptomes. Blood. 2011;118(14):e101-e111.
10. Bray PF, McKenzie SE, Edelstein LC, et al. The complex transcriptional landscape of the anucleate human platelet. BMC Genomics. 2013;14:1.
11. Kissopoulou A, Jonasson J, Lindahl TL, Osman A. Next generation sequencing analysis of human platelet PolyA1 mRNAs and rRNA-depleted total RNA. PLoS One. 2013;8(12):e81809.
12. Burkhart JM, Vaudel M, Gambaryan S, et al. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood. 2012;120(15):e73-e82.
13. Rowley JW, Weyrich AS. Coordinate expression of transcripts and proteins in platelets. Blood. 2013;121(26):5255-5256.
14. Geiger J, Burkhart JM, Gambaryan S, Walter U, Sickmann A, Zahedi RP. Response: platelet transcriptome and proteome-relation rather than correlation. Blood. 2013;121(26):5257-5258.
15. Londin ER, Hatzimichael E, Loher P, et al. The human platelet: strong transcriptome correlations among individuals associate weakly with the platelet proteome. Biol Direct. 2014;9:3.
16. Stiegler G, Fischer G, Ramanathan G, Bencur P, Weigel G, Mannhalter C. P-selectin mRNA is maintained in platelet concentrates stored at 4 degrees C. Transfusion. 2009;49(5):921-927.
17. Rowley JW, Schwertz H, Weyrich AS. Platelet mRNA: the meaning behind the message. Curr Opin Hematol. 2012;19(5):385-391.
18. Schubert S, Weyrich AS, Rowley JW. A tour through the transcriptional landscape of platelets. Blood. 2014;124(4):493-502.
19. Dixon RJ, Eperon IC, Hall L, Samani NJ. A genome-wide survey demonstrates widespread non-linear mRNA in expressed sequences from multiple species. Nucleic Acids Res. 2005;33(18):5904-5913.
20. Al-Balool HH, Weber D, Liu Y, et al. Posttranscriptional exon shuffling events in humans can be evolutionarily conserved and abundant. Genome Res. 2011;21(11):1788-1799.
21. Salzman J, Gawad C, Wang PL, Lacayo N, Brown PO. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS One. 2012;7(2):e30733.
22. Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333-338.
23. Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19(2):141-157.
24. Wang PL, Bao Y, Yee MC, et al. Circular RNA is expressed across the eukaryotic tree of life. PLoS One. 2014;9(6):e90859.
25. Caudevilla C, Serra D, Miliar A, et al. Natural trans-splicing in carnitine octanoyltransferase premRNAs in rat liver. Proc Natl Acad Sci USA. 1998;95(21):12185-12190.
26. Wu CS, Yu CY, Chuang CY, et al. Integrative transcriptome sequencing identifies trans-splicing events with important roles in human embryonic stem cell pluripotency. Genome Res. 2014;24(1):25-36.
27. Zhang XO, Wang HB, Zhang Y, Lu X, Chen LL, Yang L. Complementary sequence-mediated exon circularization. Cell. 2014;159(1):134-147.
28. Liang D, Wilusz JE. Short intronic repeat sequences facilitate circular RNA production. Genes Dev. 2014;28(20):2233-2247.
29. Ashwal-Fluss R, Meyer M, Pamudurti NR, et al. circRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014;56(1):55-66.
30. Starke S, Jost I, Rossbach O, et al. Exon circularization requires canonical splice signals. Cell Reports. 2015;10(1):103-111.
31. Conn SJ, Pillman KA, Toubia J, et al. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160(6):1125-1134.
32. Li Z, Huang C, Bao C, et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015;22(3):256-264.
33. Guo JU, Agarwal V, Guo H, Bartel DP. Expanded identification and characterization of mammalian circular RNAs. Genome Biol. 2014;15(7):409.
34. Mukherjee C, Patil DP, Kennedy BA, Bakthavachalu B, Bundschuh R, Schoenberg DR. Identification of cytoplasmic capping targets reveals a role for cap homeostasis in translation and mRNA stability. Cell Reports. 2012;2(3):674-684.
35. Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32(5):453-461.
36. Birney E, Stamatoyannopoulos JA, Dutta A, et al; ENCODE Project Consortium; NISC Comparative Sequencing Program; Baylor College of Medicine Human Genome Sequencing Center; Washington University Genome Sequencing Center; Broad Institute; Children's Hospital Oakland Research Institute. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature. 2007;447(7146):799-816.
37. Nielsen MM, Tehler D, Vang S, et al. Identification of expressed and conserved human noncoding RNAs. RNA. 2014;20(2):236-251.
38. Nürnberg ST, Rendon A, Smethurst PA, et al; HaemGen Consortium. A GWAS sequence variant for platelet volume marks an alternative DNM3 promoter in megakaryocytes near a MEIS1 binding site. Blood. 2012;120(24):4859-4868.
39. Amisten S. A rapid and efficient platelet purification protocol for platelet gene expression studies. Methods Mol Biol. 2012;788:155-172.
40. Tijssen MR, Cvejic A, Joshi A, et al. Genome-wide analysis of simultaneous GATA1/2, RUNX1, FLI1, and SCL binding in megakaryocytes identifies hematopoietic regulators. Dev Cell. 2011;20(5):597-609.
41. Salzman J, Chen RE, Olsen MN, Wang PL, Brown PO. Cell-type specific features of circular RNA expression. PLoS Genet. 2013;9(9):e1003777.
42. Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M; ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57-74.
43. Yu CY, Liu HJ, Hung LY, Kuo HC, Chuang TJ. Is an observed non-co-linear RNA product spliced in trans, in cis or just in vitro? Nucleic Acids Res. 2014;42(14):9410-9423.
44. Rybak-Wolf A, Stottmeister C, Glažar P, et al. Circular RNAs in the mammalian brain are Highly Abundant, Conserved, and Dynamically Expressed. Mol Cell. 2015;58(5):870-885.
45. Schoenberg DR, Maquat LE. Regulation of cytoplasmic mRNA decay. Nat Rev Genet. 2012;13(4):246-259.
46. Friedel CC, Dölken L, Ruzsics Z, Koszinowski UH, Zimmer R. Conserved principles of mammalian transcriptional regulation revealed by RNA half-life. Nucleic Acids Res. 2009;37(17):e115.
47. Rabani M, Levin JZ, Fan L, et al. Metabolic labeling of RNA uncovers principles of RNA production and degradation dynamics in mammalian cells. Nat Biotechnol. 2011;29(5):436-442.
48. Tani H, Akimitsu N. Genome-wide technology for determining RNA stability in mammalian cells: historical perspective and recent advantages based on modified nucleotide labeling. RNA Biol. 2012;9(10):1233-1238.
49. Lindemann S, Tolley ND, Dixon DA, et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol. 2001;154(3):485-490.
50. Zimmerman GA, Weyrich AS. Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function. Arterioscler Thromb Vasc Biol. 2008;28(3):s17-s24.
51. Cecchetti L, Tolley ND, Michetti N, Bury L, Weyrich AS, Gresele P. Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events. Blood. 2011;118(7):1903-1911.
52. Steiner M, Baldini M. Protein synthesis in aging blood platelets. Blood. 1969;33(4):628-633.
53. Gnatenko DV, Dunn JJ, McCorkle SR, Weissmann D, Perrotta PL, Bahou WF. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood. 2003;101(6):2285-2293.
54. McRedmond JP, Park SD, Reilly DF, et al. Integration of proteomics and genomics in platelets: a profile of platelet proteins and plateletspecific genes. Mol Cell Proteomics. 2004;3(2):133-144.
55. Rondina MT, Schwertz H, Harris ES, et al. The septic milieu triggers expression of spliced tissue factor mRNA in human platelets. J Thromb Haemost. 2011;9(4):748-758.
56. Hawrylowicz CM, Santoro SA, Platt FM, Unanue ER. Activated platelets express IL-1 activity. J Immunol. 1989;143(12):4015-4018.
57. Savini I, Catani MV, Arnone R, et al. Translational control of the ascorbic acid transporter SVCT2 in human platelets. Free Radic Biol Med. 2007;42(5):608-616.
58. Kieffer N, Guichard J, Farcet JP, Vainchenker W, Breton-Gorius J. Biosynthesis of major platelet proteins in human blood platelets. Eur J Biochem. 1987;164(1):189-195.
59. Weyrich AS, Dixon DA, Pabla R, et al. Signaldependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci USA. 1998;95(10):5556-5561.
60. Bachmayr-Heyda A, Reiner AT, Auer K, et al. Correlation of circular RNA abundance with proliferation-exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues. Sci Rep. 2015;5:8057.
61. Westholm JO, Miura P, Olson S, et al. Genomewide analysis of drosophila circular RNAs reveals their structural and sequence properties and agedependent neural accumulation. Cell Reports. 2014;9(5):1966-1980.
62. Li Y, Zheng Q, Bao C, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015;25(8):981-984.